63 related articles for article (PubMed ID: 21871888)
1. Transcriptional repression of the tumor suppressor DRO1 by AIB1.
Ferragud J; Avivar-Valderas A; Pla A; De Las Rivas J; Font de Mora J
FEBS Lett; 2011 Oct; 585(19):3041-6. PubMed ID: 21871888
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.
Li JV; Chien CD; Garee JP; Xu J; Wellstein A; Riegel AT
Mol Endocrinol; 2013 Jul; 27(7):1113-27. PubMed ID: 23660594
[TBL] [Abstract][Full Text] [Related]
3. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
[TBL] [Abstract][Full Text] [Related]
4. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.
Lauritsen KJ; List HJ; Reiter R; Wellstein A; Riegel AT
Oncogene; 2002 Oct; 21(47):7147-55. PubMed ID: 12370804
[TBL] [Abstract][Full Text] [Related]
5. Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
Kushner MH; Ory V; Graham GT; Sharif GM; Kietzman WB; Thevissen S; Yuan M; Schmidt MO; Wellstein A; Riegel AT
EMBO Rep; 2020 Jan; 21(1):e48741. PubMed ID: 31788936
[TBL] [Abstract][Full Text] [Related]
6. ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.
Dong XY; Sun X; Guo P; Li Q; Sasahara M; Ishii Y; Dong JT
J Biol Chem; 2010 Oct; 285(43):32801-32809. PubMed ID: 20720010
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma.
Heck S; Rom J; Thewes V; Becker N; Blume B; Sinn HP; Deuschle U; Sohn C; Schneeweiss A; Lichter P
Cancer Res; 2009 Jun; 69(12):5186-93. PubMed ID: 19491275
[TBL] [Abstract][Full Text] [Related]
8. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of AIB1 expression in human breast cancer.
Iwase H; Omoto Y; Toyama T; Yamashita H; Hara Y; Sugiura H; Zhang Z
Breast Cancer Res Treat; 2003 Aug; 80(3):339-45. PubMed ID: 14503806
[TBL] [Abstract][Full Text] [Related]
10. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.
Torres-Arzayus MI; Font de Mora J; Yuan J; Vazquez F; Bronson R; Rue M; Sellers WR; Brown M
Cancer Cell; 2004 Sep; 6(3):263-74. PubMed ID: 15380517
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
12. AIB1 shows variation in interaction with ERβTAD and expression as a function of age in mouse brain.
Paramanik V; Thakur MK
Biogerontology; 2011 Aug; 12(4):321-8. PubMed ID: 21442277
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
[TBL] [Abstract][Full Text] [Related]
14. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
16. Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.
Torres-Arzayus MI; Yuan J; DellaGatta JL; Lane H; Kung AL; Brown M
Cancer Res; 2006 Dec; 66(23):11381-8. PubMed ID: 17145884
[TBL] [Abstract][Full Text] [Related]
17. Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.
Chien CD; Kirilyuk A; Li JV; Zhang W; Lahusen T; Schmidt MO; Oh AS; Wellstein A; Riegel AT
J Biol Chem; 2011 Jul; 286(30):26813-27. PubMed ID: 21636853
[TBL] [Abstract][Full Text] [Related]
18. Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.
Garee JP; Chien CD; Li JV; Wellstein A; Riegel AT
Mol Endocrinol; 2014 Jun; 28(6):846-59. PubMed ID: 24678732
[TBL] [Abstract][Full Text] [Related]
19. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
Yoshitomi T; Kawakami K; Enokida H; Chiyomaru T; Kagara I; Tatarano S; Yoshino H; Arimura H; Nishiyama K; Seki N; Nakagawa M
Oncol Rep; 2011 Jun; 25(6):1661-8. PubMed ID: 21479368
[TBL] [Abstract][Full Text] [Related]
20. Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation.
You D; Zhao H; Wang Y; Jiao Y; Lu M; Yan S
Mol Cells; 2016 Sep; 39(9):663-8. PubMed ID: 27665502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
